Jon Huyghe

3PUBLICATIONS
5CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Synchrotrons and accelerators not elsewhere classifiedHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Sep 01, 2025
TAB2 controls a TAK1-independent cell death checkpoint at the level of TNFR1 complex II in the TNF pathway.

Tom Delanghe, Mike Vadi, Annelore Haems

|Apr 04, 2023
LC3-independent autophagy is vital to prevent TNF cytotoxicity.

Dario Priem, Jon Huyghe, Mathieu Jm Bertrand

|Dec 15, 2022
ATG9A prevents TNF cytotoxicity by an unconventional lysosomal targeting pathway.

Jon Huyghe, Dario Priem, Lisette Van Hove

Pageof 1